Form 4: Metagenomi CFO Sells Shares for Tax Obligations

Metagenomi's Chief Financial Officer, Pamela Wapnick, sold 1,576 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Pamela Wapnick, Chief Financial Officer of Metagenomi, Inc. (MGX), reported a transaction involving the company's common stock.
• On December 5, 2025, 1,576 shares of common stock were sold at a price of $1.7719 per share.
• The sale was not a volitional trade but an automatic transaction to satisfy tax withholding obligations upon the vesting of restricted stock units granted on April 1, 2024.
• Following this transaction, Pamela Wapnick beneficially owns 188,956 shares of Metagenomi common stock directly.

Sentiment

Score: 5

Explanation: The transaction is a non-volitional sale for tax withholding purposes, which is a neutral event and does not reflect a change in management's confidence or the company's operational performance.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• The shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on April 1, 2024, and does not represent a volitional trade by the Reporting Person.

Industry Context

This insider transaction report (Form 4) is a routine disclosure for publicly traded companies, detailing changes in beneficial ownership by officers, directors, and significant shareholders. It does not provide information related to broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: The sale represents a minor, non-volitional reduction in insider ownership, which is generally not seen as a significant signal of company health or future prospects.

Key Dates

Recommendation

The reported transaction is a routine, non-volitional sale of shares by the Chief Financial Officer to cover tax obligations associated with RSU vesting. Such transactions are common and typically do not indicate a change in the insider's view of the company's prospects or fundamental value. Therefore, it provides no new information that would warrant a change in investment recommendation.

Keywords

Metagenomi, MGX, Form 4, Insider Transaction, Stock Sale, CFO, Pamela Wapnick, RSU Vesting, Tax Withholding